Liver-eye axis in metabolic syndrome: integrated evidence from mendelian randomization, single-cell sequencing, and clinical sample validation.

Yuan TH, Fang YF, Zhang GH, Zhang HR, Zhou ZY, Yue ZS, Li B, Wang L, Wang YS, Dou GR

Open source

DOI
10.3389/fendo.2026.1878316
Published
2026
Container
Frontiers in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1878316,
  title = {Liver-eye axis in metabolic syndrome: integrated evidence from mendelian randomization, single-cell sequencing, and clinical sample validation.},
  author = {Yuan TH and Fang YF and Zhang GH and Zhang HR and Zhou ZY and Yue ZS and Li B and Wang L and Wang YS and Dou GR},
  year = {2026},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2026.1878316},
  url = {https://doi.org/10.3389/fendo.2026.1878316}
}

RIS

TY  - JOUR
TI  - Liver-eye axis in metabolic syndrome: integrated evidence from mendelian randomization, single-cell sequencing, and clinical sample validation.
AU  - Yuan TH
AU  - Fang YF
AU  - Zhang GH
AU  - Zhang HR
AU  - Zhou ZY
AU  - Yue ZS
AU  - Li B
AU  - Wang L
AU  - Wang YS
AU  - Dou GR
PY  - 2026
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1878316
UR  - https://doi.org/10.3389/fendo.2026.1878316
ER  - 

APA

TH, Y., YF, F., GH, Z., HR, Z., ZY, Z., ZS, Y., B, L., L, W., YS, W., & GR, D. (2026). Liver-eye axis in metabolic syndrome: integrated evidence from mendelian randomization, single-cell sequencing, and clinical sample validation.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1878316

Source records